TSXV: CNO Statistics

Total Valuation

California Nanotechnologies has a market cap or net worth of CAD 37.48 million. The enterprise value is 40.16 million.

Market Cap	37.48M
Enterprise Value	40.16M

Important Dates

The next estimated earnings date is Monday, January 27, 2025.

Earnings Date	Jan 27, 2025
Ex-Dividend Date	n/a

Share Statistics

California Nanotechnologies has 45.71 million shares outstanding. The number of shares has increased by 43.12% in one year.

Current Share Class	n/a
Shares Outstanding	45.71M
Shares Change (YoY)	+43.12%
Shares Change (QoQ)	+8.80%
Owned by Insiders (%)	13.48%
Owned by Institutions (%)	3.75%
Float	32.57M

Valuation Ratios

The trailing PE ratio is 162.52.

PE Ratio	162.52
Forward PE	n/a
PS Ratio	4.66
PB Ratio	32.57
P/TBV Ratio	34.82
P/FCF Ratio	81.74
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 16.39, with an EV/FCF ratio of 87.59.

EV / Earnings	171.49
EV / Sales	5.50
EV / EBITDA	16.39
EV / EBIT	19.74
EV / FCF	87.59

Financial Position

The company has a current ratio of 1.04, with a Debt / Equity ratio of 3.30.

Current Ratio	1.04
Quick Ratio	0.48
Debt / Equity	3.30
Debt / EBITDA	1.46
Debt / FCF	7.78
Interest Coverage	8.60

Financial Efficiency

Return on equity (ROE) is 249.54% and return on invested capital (ROIC) is 44.90%.

Return on Equity (ROE)	249.54%
Return on Assets (ROA)	28.07%
Return on Capital (ROIC)	44.90%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	1.61
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +245.83% in the last 52 weeks. The beta is 1.60, so California Nanotechnologies's price volatility has been higher than the market average.

Beta (5Y)	1.60
52-Week Price Change	+245.83%
50-Day Moving Average	1.15
200-Day Moving Average	0.82
Relative Strength Index (RSI)	36.21
Average Volume (20 Days)	82,348

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, California Nanotechnologies had revenue of CAD 7.30 million and earned 234,196 in profits. Earnings per share was 0.01.

Revenue	7.30M
Gross Profit	5.28M
Operating Income	2.03M
Pretax Income	233,123
Net Income	234,196
EBITDA	2.20M
EBIT	2.03M
Earnings Per Share (EPS)	0.01

Full Income Statement

Balance Sheet

The company has 887,270 in cash and 3.57 million in debt, giving a net cash position of -2.68 million or -0.06 per share.

Cash & Cash Equivalents	887,270
Total Debt	3.57M
Net Cash	-2.68M
Net Cash Per Share	-0.06
Equity (Book Value)	1.08M
Book Value Per Share	0.03
Working Capital	155,079

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 1.03 million and capital expenditures -568,309, giving a free cash flow of 458,519.

Operating Cash Flow	1.03M
Capital Expenditures	-568,309
Free Cash Flow	458,519
FCF Per Share	0.01

Full Cash Flow Statement

Margins

Gross margin is 72.32%, with operating and profit margins of 27.85% and 3.21%.

Gross Margin	72.32%
Operating Margin	27.85%
Pretax Margin	3.19%
Profit Margin	3.21%
EBITDA Margin	30.09%
EBIT Margin	27.85%
FCF Margin	6.28%

Dividends & Yields

California Nanotechnologies does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-43.12%
Shareholder Yield	-43.12%
Earnings Yield	n/a
FCF Yield	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

California Nanotechnologies has an Altman Z-Score of 2.65. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.65
Piotroski F-Score	n/a